Investors Purchase Large Volume of Call Options on HCP (HCP)

Share on StockTwits

HCP, Inc. (NYSE:HCP) was the target of unusually large options trading on Wednesday. Stock investors bought 4,280 call options on the company. This represents an increase of approximately 1,376% compared to the typical volume of 290 call options.

Shares of NYSE HCP opened at $29.81 on Friday. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 1.21. HCP has a fifty-two week low of $21.48 and a fifty-two week high of $30.26. The company has a market capitalization of $14.01 billion, a PE ratio of 15.29, a price-to-earnings-growth ratio of 5.56 and a beta of 0.28.

HCP (NYSE:HCP) last issued its quarterly earnings results on Wednesday, October 31st. The real estate investment trust reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.10. HCP had a return on equity of 3.06% and a net margin of 9.16%. The firm had revenue of $456.00 million for the quarter, compared to the consensus estimate of $456.59 million. During the same period in the prior year, the business posted $0.48 earnings per share. The company’s revenue for the quarter was up .4% on a year-over-year basis. On average, equities research analysts anticipate that HCP will post 1.82 earnings per share for the current year.

A number of equities analysts recently commented on the company. BMO Capital Markets raised HCP from a “market perform” rating to an “outperform” rating and increased their price target for the company from $30.00 to $33.00 in a research note on Wednesday, January 9th. Robert W. Baird raised HCP from a “neutral” rating to an “outperform” rating in a research note on Monday, January 7th. Scotiabank initiated coverage on HCP in a research note on Monday, December 10th. They issued an “outperform” rating and a $32.00 price objective for the company. Zacks Investment Research reaffirmed a “sell” rating on shares of HCP in a research note on Tuesday, November 13th. Finally, ValuEngine raised HCP from a “hold” rating to a “buy” rating in a research note on Monday, November 12th. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $27.39.

In other news, COO Thomas Klaritch sold 82,532 shares of the company’s stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $29.51, for a total value of $2,435,519.32. Following the completion of the transaction, the chief operating officer now owns 256,280 shares of the company’s stock, valued at $7,562,822.80. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.14% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Moody National Bank Trust Division lifted its position in HCP by 1.3% during the 4th quarter. Moody National Bank Trust Division now owns 38,592 shares of the real estate investment trust’s stock worth $1,078,000 after acquiring an additional 477 shares during the period. Contravisory Investment Management Inc. raised its stake in shares of HCP by 5.6% during the 4th quarter. Contravisory Investment Management Inc. now owns 14,353 shares of the real estate investment trust’s stock valued at $401,000 after buying an additional 765 shares during the last quarter. Lourd Capital LLC raised its stake in shares of HCP by 12.5% during the 4th quarter. Lourd Capital LLC now owns 9,027 shares of the real estate investment trust’s stock valued at $252,000 after buying an additional 1,006 shares during the last quarter. Curbstone Financial Management Corp raised its stake in shares of HCP by 3.2% during the 4th quarter. Curbstone Financial Management Corp now owns 51,700 shares of the real estate investment trust’s stock valued at $1,335,000 after buying an additional 1,600 shares during the last quarter. Finally, First Hawaiian Bank increased its stake in shares of HCP by 21.5% in the 4th quarter. First Hawaiian Bank now owns 9,900 shares of the real estate investment trust’s stock valued at $277,000 after purchasing an additional 1,750 shares in the last quarter. Institutional investors own 88.83% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This report was first reported by Week Herald and is the property of of Week Herald. If you are viewing this report on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this report can be accessed at https://weekherald.com/2019/01/18/investors-purchase-large-volume-of-call-options-on-hcp-hcp.html.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Featured Story: How Do Investors Open a Backdoor Roth IRA?

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply